Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer
Jungwon Kim(The University of Tokyo), Toyomasa Katagiri(National Institute of Biomedical Innovation, Health and Nutrition), Tatsuhiko Tsunoda(University of California San Diego), Miki Akiyama(Keio University), Toshihiko Nishidate(The University of Tokyo), Meng‐Lay Lin(Wellcome Sanger Institute), Jae‐Hyun Park(St. Jude Medical Center), Yusuke Nakamura(Rissho University), Yataro Daigo(The University of Tokyo), Tomomi Ueki(The University of Tokyo), Arata Shimo(The University of Tokyo)
Cited by 63
Related Papers
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
|Nature Genetics|2009|1.3k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
|Nature|1998|804
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
|Nature Genetics|2009|788